A species-altering technology is said to need careful regulation before being released into the wild.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
The world’s largest genome project will be carried out on instruments from the California sequencing company.
A way of capturing cancer cells from the bloodstream opens a new front in personal cancer treatment.
Critics call emphasis on large-scale computer simulations in EU brain project premature.
In a remarkable study, a paralyzed woman used her mind to control a robotic arm. If only there were a realistic way to get this technology out of the lab and into real life.
How a California father made an end run around medicine to decode his son’s DNA.
A $70 million program will try to develop brain implants able to regulate emotions in the mentally ill.
To protect lucrative business servicing machines, GE turns to the industrial Internet.
As everyday objects get connected, brace yourself for network effects, says one economist.
Are companies ready for billions of everyday objects to join the Internet?